Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | THRB | P10828 | 3/20 | 0.36 |
| ▸ | RECQL | P46063 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | RXRG | P48443 | 1/20 | 0.36 |
| ▸ | SNCA | P37840 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29929178 | 0.85 | TDP1 (0.42) | LMNAMAPTMEN1KMT2ATDP1 | |
| SCHEMBL559385 | 0.85 | TDP1 (0.42) | LMNAMAPTMEN1KMT2ATDP1 | |
| SCHEMBL17250078 | 0.84 | MAPT (0.42) | LMNAMAPTMEN1KMT2ATDP1 | |
| SCHEMBL1367336 | 0.80 | LMNA (0.61) | LMNAMAPTMEN1KMT2ATDP1 | |
| SCHEMBL14781535 | 0.80 | ALDH1A1 (0.33) | LMNATDP1KDM4ERXRARXRB | |
| Water SCHEMBL6796016 | 0.79 | LMNA (0.60) | LMNAMAPTMEN1KMT2ATDP1 | |
| SCHEMBL10093777 | 0.79 | LMNA (0.46) | LMNAMAPTMEN1KMT2ATDP1 | |
| SCHEMBL26319348 | 0.79 | VDR (0.45) | LMNAMAPTMEN1KMT2ATDP1 | |
| Sulfuric Acid SCHEMBL4614646 | 0.78 | MAPT (0.42) | LMNAMAPTTDP1KDM4EAPEX1 | |
| SCHEMBL12146299 | 0.78 | TDP1 (0.58) | LMNAMAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4234566-A1 | MODIFIED NUCLEOSIDE OR NUCLEOTIDE | BGI Shenzhen (CN) | 2023-08-30 | — | — | EP | disclosed |
| US-20160356681-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | Life Technologies Corporation | 2016-12-08 | — | — | US | disclosed |
| US-9423323-B2 | Modified carbocyanine dyes and their conjugates | Life Technologies Corporation (US) | 2016-08-23 | — | — | US | disclosed |
| US-20150259535-A1 | Fluorescent dyes | ANASPEC INC (US) | 2015-09-17 | — | — | US | disclosed |
| US-20150247785-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | Life Technologies Corporation | 2015-09-03 | — | — | US | disclosed |
| US-9110069-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2015-08-18 | — | — | US | disclosed |
| US-20150218380-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | Life Technologies Corporation | 2015-08-06 | — | — | US | disclosed |
| US-9018396-B2 | Modified carbocyanine dyes and their conjugates | Life Technologies Corporation (US) | 2015-04-28 | — | — | US | disclosed |
| US-8999690-B2 | Kits for analysis of biological samples | ANASPEC INCORPORATED (US) | 2015-04-07 | — | — | US | disclosed |
| EP-1322710-B2 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | LIFE TECHNOLOGIES CORP (US) | 2015-02-18 | — | — | EP | disclosed |
| US-6974873-B2 | Modified carbocyanine dyes and their conjugates | MOLECULAR PROBES, INC. (US) | 2005-12-13 | — | — | US | disclosed |
| US-20050202565-A1 | Luminescent compounds | SETA BIOMEDICALS, LLC | 2005-09-15 | — | — | US | disclosed |
| US-20040166515-A1 | Luminescent compounds | TERPETSCHNIG, EWALD A. | 2004-08-26 | — | — | US | disclosed |
| US-20030235846-A1 | Luminescent compounds | TERPTETSCHNIG, EWALD A. | 2003-12-25 | — | — | US | disclosed |
| EP-1078023-A4 | LUMINESCENT COMPOUNDS | TERPETSCHNIG EWALD A (US) | 2003-03-26 | — | — | EP | disclosed |
| US-6538129-B1 | Luminescent compounds | Terpetschnig, Ewald A. | 2003-03-25 | — | — | US | disclosed |
| US-20020077487-A1 | Modified carbocyanine dyes and their conjugates | MOLECULAR PROBES, INC. | 2002-06-20 | — | — | US | disclosed |
| US-20020064794-A1 | Modified carbocyanine dyes and their conjugates | MOLECULAR PROBES, INC. | 2002-05-30 | — | — | US | disclosed |
| EP-1078023-A1 | LUMINESCENT COMPOUNDS | Terpetschnig, Ewald A. (US) | 2001-02-28 | — | — | EP | disclosed |
| WO-1999051702-A1 | LUMINESCENT COMPOUNDS | TERPETSCHNIG EWALD A (US) | 1999-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077487-A1 | Modified carbocyanine dyes and their conjugates | IK, CBR3, DRD5 | LMNA 2822/4885MAPT 2463/4885MEN1 1243/4885 |
| US-20030235846-A1 | Luminescent compounds | CROCC, NR2E1, NDC1 | LMNA 813/4885MAPT 4435/4885MEN1 4116/4885 |
| US-20160356681-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | IK, CBR3, DRD5 | LMNA 2822/4885MAPT 2463/4885MEN1 1243/4885 |
| US-20150218380-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | IK, CBR3, DRD5 | LMNA 2822/4885MAPT 2463/4885MEN1 1243/4885 |
| US-20150247785-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | IK, CBR3, DRD5 | LMNA 2822/4885MAPT 2463/4885MEN1 1243/4885 |
| US-20040166515-A1 | Luminescent compounds | RORC, NR2E3, RORB | LMNA 1196/4885MAPT 4542/4885MEN1 3748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.